Next Article in Journal
Changes in Iron Metabolism Induced by Anti-Interleukin-6 Receptor Monoclonal Antibody are Associated with an Increased Risk of Infection
Next Article in Special Issue
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
Previous Article in Journal
Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against H2O2- and Aβ1-42-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells
Previous Article in Special Issue
Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin Amyloidosis
 
 
Review

Article Versions Notes

Action Date Notes Link
article xml file uploaded 24 June 2019 12:26 CEST Original file -
article xml uploaded. 24 June 2019 12:26 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/12/2/99/xml
article pdf uploaded. 24 June 2019 12:26 CEST Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/12/2/99/pdf
article html file updated 24 June 2019 12:28 CEST Original file -
article html file updated 5 July 2019 08:07 CEST Update -
article html file updated 5 July 2019 14:44 CEST Update -
article html file updated 22 October 2019 09:54 CEST Update -
article html file updated 12 February 2020 21:44 CET Update -
article html file updated 20 July 2022 15:05 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/12/2/99/html
Back to TopTop